Drugs Made In America Acquisition II Corp.

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.

DMIINasdaqFinancial ServicesShell Companies
$10.06 -0.01 (-0.10%)

Company Overview

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.

Price Chart

Historical Trend (Absolute Values)
DMII Price
05/1305/2105/29

Financial Metrics

Market Capitalization$642.10M
P/E Ratio77.3846
Earnings Per Share (EPS)$0
Dividend Yield
Beta (Volatility)
Price to Book (P/B)-36.0573
52-Week Range$9.86 - $10.07

LAST SCRARED: May 31, 2026

Compare DMII

Analyze valuation multiples and growth parameters side-by-side with other public equities.

Compare Stock Now
VersusHub

© 2026 VersusHub. All rights reserved.